Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH)
SAN DIEGO, Dec. 9, 2013 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results